These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 10558907

  • 1. Hepatoma-specific gene therapy through retrovirus-mediated and targeted gene transfer using an adenovirus carrying the ecotropic receptor gene.
    Uto H, Ido A, Hori T, Hirono S, Hayashi K, Tamaoki T, Tsubouchi H.
    Biochem Biophys Res Commun; 1999 Nov 19; 265(2):550-5. PubMed ID: 10558907
    [Abstract] [Full Text] [Related]

  • 2. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
    Ido A, Nakata K, Kato Y, Nakao K, Murata K, Fujita M, Ishii N, Tamaoki T, Shiku H, Nagataki S.
    Cancer Res; 1995 Jul 15; 55(14):3105-9. PubMed ID: 7541712
    [Abstract] [Full Text] [Related]

  • 3. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
    Kanai F, Shiratori Y, Yoshida Y, Wakimoto H, Hamada H, Kanegae Y, Saito I, Nakabayashi H, Tamaoki T, Tanaka T, Lan KH, Kato N, Shiina S, Omata M.
    Hepatology; 1996 Jun 15; 23(6):1359-68. PubMed ID: 8675152
    [Abstract] [Full Text] [Related]

  • 4. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K.
    J Gene Med; 2004 Mar 15; 6(3):288-99. PubMed ID: 15026990
    [Abstract] [Full Text] [Related]

  • 5. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
    Ido A, Uto H, Moriuchi A, Nagata K, Onaga Y, Onaga M, Hori T, Hirono S, Hayashi K, Tamaoki T, Tsubouchi H.
    Cancer Res; 2001 Apr 01; 61(7):3016-21. PubMed ID: 11306481
    [Abstract] [Full Text] [Related]

  • 6. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
    Mawatari F, Tsuruta S, Ido A, Ueki T, Nakao K, Kato Y, Tamaoki T, Ishii N, Nakata K.
    Cancer Gene Ther; 1998 Apr 01; 5(5):301-6. PubMed ID: 9824049
    [Abstract] [Full Text] [Related]

  • 7. Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model.
    Bilbao R, Gérolami R, Bralet MP, Qian C, Tran PL, Tennant B, Prieto J, Bréchot C.
    Cancer Gene Ther; 2000 May 01; 7(5):657-62. PubMed ID: 10830712
    [Abstract] [Full Text] [Related]

  • 8. Retrovirus-mediated gene therapy for hepatocellular carcinoma with reversely oriented therapeutic gene expression regulated by alpha-fetoprotein enhancer/promoter.
    Ishikawa H, Nakata K, Mawatari F, Ueki T, Tsuruta S, Ido A, Nakao K, Kato Y, Ishii N, Eguchi K.
    Biochem Biophys Res Commun; 2001 Oct 05; 287(4):1034-40. PubMed ID: 11573968
    [Abstract] [Full Text] [Related]

  • 9. Hepatoma cell-specific ganciclovir-mediated toxicity of a lentivirally transduced HSV-TkEGFP fusion protein gene placed under the control of rat alpha-fetoprotein gene regulatory sequences.
    Uch R, Gérolami R, Faivre J, Hardwigsen J, Mathieu S, Mannoni P, Bagnis C.
    Cancer Gene Ther; 2003 Sep 05; 10(9):689-95. PubMed ID: 12944988
    [Abstract] [Full Text] [Related]

  • 10. [Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase genes expressed in vascular endothelial cells].
    Liu XP, Li BJ, Zhang C.
    Ai Zheng; 2006 Feb 05; 25(2):179-84. PubMed ID: 16480582
    [Abstract] [Full Text] [Related]

  • 11. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D, Vogels R, Havenga M, Avezaat CJ, Bout A, Smitt PS.
    Cancer Res; 2001 Dec 15; 61(24):8743-50. PubMed ID: 11751394
    [Abstract] [Full Text] [Related]

  • 12. HSV-tk gene therapy for human renal cell carcinoma in nude mice.
    Pulkkanen KJ, Parkkinen JJ, Laukkanen JM, Kettunen MI, Tyynela K, Kauppinen RA, Ala-Opas MY, Yla-Herttuala S.
    Cancer Gene Ther; 2001 Jul 15; 8(7):529-36. PubMed ID: 11498775
    [Abstract] [Full Text] [Related]

  • 13. Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene.
    Wills KN, Huang WM, Harris MP, Machemer T, Maneval DC, Gregory RJ.
    Cancer Gene Ther; 1995 Sep 15; 2(3):191-7. PubMed ID: 8528962
    [Abstract] [Full Text] [Related]

  • 14. Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma.
    Ishikawa H, Nakata K, Mawatari F, Ueki T, Tsuruta S, Ido A, Nakao K, Kato Y, Ishii N, Eguchi K.
    Gene Ther; 1999 Apr 15; 6(4):465-70. PubMed ID: 10476206
    [Abstract] [Full Text] [Related]

  • 15. [The adenovirus-mediated HSV-TK/GCV suicide gene system in the treatment of tongue carcinoma cell line].
    Huang H, Wang A.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Nov 15; 36(6):457-60. PubMed ID: 11930726
    [Abstract] [Full Text] [Related]

  • 16. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
    Xing Y, Lu G, Xiao Y, Zeng F, Zhang Q, Xiong P, Feng W.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 10; 82(21):1484-7. PubMed ID: 12509912
    [Abstract] [Full Text] [Related]

  • 17. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
    Määttä AM, Korja S, Venhoranta H, Hakkarainen T, Pirinen E, Heikkinen S, Pellinen R, Mäkinen K, Wahlfors J.
    Int J Mol Med; 2006 Nov 10; 18(5):901-8. PubMed ID: 17016620
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy.
    Xie Y, Gilbert JD, Kim JH, Freytag SO.
    Clin Cancer Res; 1999 Dec 10; 5(12):4224-32. PubMed ID: 10632364
    [Abstract] [Full Text] [Related]

  • 19. Adenovirus E1a protein enhances the cytotoxic effects of the herpes thymidine kinase-ganciclovir system.
    Parada C, Hernández Losa J, Guinea J, Sánchez-Arévalo V, Fernández Soria V, Alvarez-Vallina L, Sánchez-Prieto R, Ramón y Cajal S.
    Cancer Gene Ther; 2003 Feb 10; 10(2):152-60. PubMed ID: 12536204
    [Abstract] [Full Text] [Related]

  • 20. Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma.
    Sakai Y, Kaneko S, Nakamoto Y, Kagaya T, Mukaida N, Kobayashi K.
    Cancer Gene Ther; 2001 Oct 10; 8(10):695-704. PubMed ID: 11687892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.